Sernova Provides Corporate Update and Results of 2013 Annual General Meeting
May 09, 2013 06:00 ET
|
Sernova Corp
LONDON, ONTARIO--(Marketwired - May 9, 2013) - Sernova Corp. (TSX VENTURE:SVA), provides a corporate update on the clinical development of the Cell Pouch™ and projections for 2013....
Sernova Issues Additional Finder Warrants, Cancels Options
April 05, 2013 06:00 ET
|
Sernova Corp
LONDON, ONTARIO--(Marketwired - April 5, 2013) - Sernova Corp. (TSX VENTURE:SVA) announced further to the completion of the non-brokered private placement on February 19, 2013, consisting...
Sernova Awarded Funding to Optimize Its Sertolin(TM) Local Therapeutic Cell Anti-Rejection Technology for the Treatment of Chronic Diseases
March 25, 2013 06:00 ET
|
Sernova Corp
LONDON, ONTARIO--(Marketwire - March 25, 2013) - Sernova Corp. ("Sernova" or the "Company") (TSX VENTURE:SVA) a clinical stage company today announced that it has been awarded a third...
Sernova and Centre for Commercialization of Regenerative Medicine Partner to Treat Chronic Diseases
February 28, 2013 06:00 ET
|
Centre for Commercialization of Regenerative Medicine (CCRM);Sernova Corp.
TORONTO, ONTARIO and LONDON, ONTARIO--(Marketwire - Feb. 28, 2013) - The Centre for Commercialization of Regenerative Medicine (CCRM) is pleased to announce the addition of Sernova Corp....
Sernova Completes Non-Brokered Private Placement
February 19, 2013 06:00 ET
|
Sernova Corp.
LONDON, ONTARIO--(Marketwire - Feb. 19, 2013) -
NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Sernova Corp. ("Sernova" or the...
Sernova Announces Non-Brokered Private Placement
January 21, 2013 06:00 ET
|
Sernova Corp.
LONDON, ONTARIO--(Marketwire - Jan. 21, 2013) -
NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Sernova Corp. ("Sernova" or the...
Sernova's Novel Method Evaluates Islets Prior to Transplantation and Predicts Their Ability to Reverse Diabetes Post Transplantation
December 04, 2012 06:00 ET
|
Sernova Corp.
LONDON, ONTARIO--(Marketwire - Dec. 4, 2012) - Sernova Corp. ("Sernova" or the "Company") (TSX VENTURE:SVA) today announced the publication of a novel, sensitive and rapid method...
Sernova to Present at Rodman & Renshaw Annual Global Investment Conference
September 04, 2012 06:00 ET
|
Sernova Corp.
LONDON, ONTARIO--(Marketwire - Sept. 4, 2012) - Sernova Corp. ("Sernova" or the "Company") (TSX VENTURE:SVA) today announced that Dr. Philip Toleikis, President and CEO, will present at...
World First: Islet Transplant Into Man Using Sernova's Cell Pouch(TM) for Treatment of Diabetes
August 16, 2012 06:00 ET
|
Sernova Corp.
LONDON, ONTARIO and EDMONTON, ALBERTA--(Marketwire - Aug. 16, 2012) - Sernova Corp. ("Sernova" or the "Company") (TSX VENTURE:SVA) and the University of Alberta today announced the...
Sernova Announces Exercise of Warrants
June 06, 2012 06:00 ET
|
Sernova Corp
LONDON, ONTARIO--(Marketwire - June 6, 2012) - Sernova Corp. ("Sernova" or the "Company") (TSX VENTURE:SVA) is pleased to announce that, since mid-April, it has received gross proceeds of...